RIVM formulates criteria for R&D of sustainable pharmaceuticals
From 1 June 2022, heel prick test also screens for muscle disease SMA, bringing number of screened diseases to 26
From 1 June 2022, the heel prick test for Dutch newborns will also screen for spinal muscular atrophy (SMA). SMA is a serious hereditary muscle condition. Detecting this disease at an early stage enables early treatment.
Tailor-made information will help immigrants make decisions on taking part in screening programmes
RIVM calls for increased involvement of scientific community in solving plastic crisis
Breast cancer screening resumes on Bonaire after COVID-19 hiatus
Women aged 50 to 75 years on Bonaire can participate in the breast cancer screening programme again as of Wednesday, May 26, 2021. This was temporarily halted in 2020 due to the COVID-19 pandemic.
Method for safe and sustainable recycling of waste
The method developed by RIVM to assess whether waste treatment is sufficiently safe and sustainable, can contribute to the European ambitions for a safe and more circular economy.
Population screening programmes temporarily on hold
Due to the novel coronavirus (COVID-19) outbreak, the health care capacity in the Netherlands is expected to come under severe pressure in the coming period.
A guide for the safe reuse of diaper and incontinence materials
RIVM has developed a step-by-step plan for the safe reuse of diapers and incontinence material. This plan provides recyclers and licensing authorities with tools to carry out a risk assessment.